Medication use in childhood dystonia

European Journal of Paediatric Neurology

Volumn 20, Issue 4, 2016, Pages 625-629

  Lumsden, Daniel E ^a   Kaminska, Margaret ^a   Tomlin, Stephen ^a   Lin, Jean Pierre ^a  

^a EVELINA LONDON CHILDREN S HOSPITAL   (United Kingdom)

Author keywords

Childhood; Complications; Dystonia; Medication

Indexed keywords

BACLOFEN; DIAZEPAM; LEVODOPA; TRIHEXYPHENIDYL; ANTIPARKINSON AGENT; CENTRAL MUSCLE RELAXANT; CHLORAL HYDRATE; HYPNOTIC SEDATIVE AGENT;

ARTICLE; CHILD; CHILDHOOD DISEASE; CHILDHOOD DYSTONIA; DISEASE DURATION; DRUG RESPONSE; DYSTONIA; FUNCTIONAL STATUS; GROSS MOTOR FUNCTION CLASSIFICATION SYSTEM; HUMAN; MAJOR CLINICAL STUDY; PATIENT REFERRAL; PHARMACEUTICAL CARE; PHENOTYPE; PREVALENCE; PRIORITY JOURNAL; RISK ASSESSMENT; SCHOOL CHILD; SPASTICITY; ADOLESCENT; COHORT ANALYSIS; DRUG-RELATED SIDE EFFECTS AND ADVERSE REACTIONS; DYSTONIC DISORDERS; FEMALE; MALE; RISK FACTOR; STATISTICAL MODEL;

ADOLESCENT; ANTIPARKINSON AGENTS; BACLOFEN; CHILD; CHLORAL HYDRATE; COHORT STUDIES; DIAZEPAM; DRUG-RELATED SIDE EFFECTS AND ADVERSE REACTIONS; DYSTONIA; DYSTONIC DISORDERS; FEMALE; HUMANS; HYPNOTICS AND SEDATIVES; LEVODOPA; LOGISTIC MODELS; MALE; MUSCLE RELAXANTS, CENTRAL; RISK FACTORS; TRIHEXYPHENIDYL;

EID: 84959193121     PISSN: 10903798     EISSN: 15322130     Source Type: Journal    
DOI: 10.1016/j.ejpn.2016.02.003     Document Type: Article

References (19)

1. T.D. Sanger, D. Chen, D.L. Fehlings, and et al. Definition and classification of hyperkinetic movements in childhood Mov Disord 25 11 2010 1538 1549
2. A. Roubertie, F. Rivier, V. Humbertclaude, and et al. The varied etiologies of childhood-onset dystonia Rev Neurol Paris 158 4 2002 413 424
3. J.P. Lin, D.E. Lumsden, H. Gimeno, and M. Kaminska The impact and prognosis for dystonia in childhood including dystonic cerebral palsy: a clinical and demographic tertiary cohort study J Neurol Neurosurg Psychiatry 85 11 2014 1239 1244
4. A. Roubertie, L.L. Mariani, E. Fernandez-Alvarez, D. Doummar, and E. Roze Treatment for dystonia in childhood Eur J Neurol 19 10 2012 1292 1299
5. J.W. Mink Special concerns in defining, studying, and treating dystonia in children Mov Disord 28 7 2013 921 925
6. S.B. Bressman Dystonia genotypes, phenotypes, and classification Adv Neurol 94 2004 101 107
7. H. Gimeno, A. Gordon, K. Tustin, and J.P. Lin Functional priorities in daily life for children and young people with dystonic movement disorders and their families Eur J Paediatr Neurol. 17 2 2013 161 168
8. Y. Balash, and N. Giladi Efficacy of pharmacological treatment of dystonia: evidence-based review including meta-analysis of the effect of botulinum toxin and other cure options Eur J Neurol 11 6 2004 361 370
9. N. Tickner, J.R. Apps, S. Keady, and A.G. Sutcliffe An overview of drug therapies used in the treatment of dystonia and spasticity in children Arch Dis Child Educ Pract Ed 97 6 2012 230 235
10. R. Palisano, P. Rosenbaum, S. Walter, D. Russell, E. Wood, and B. Galuppi Development and reliability of a system to classify gross motor function in children with cerebral palsy Dev Med Child Neurol 39 4 1997 214 223
11. P.E. Greene, and S. Fahn Baclofen in the treatment of idiopathic dystonia in children Mov Disord 7 1 1992 48 52
12. P. Greene Baclofen in the treatment of dystonia Clin Neuropharmacol 15 4 1992 276 288
13. M.H. Anca, T.F. Zaccai, S. Badarna, A.M. Lozano, A.E. Lang, and N. Giladi Natural history of Oppenheim's dystonia (DYT1) in Israel J Child Neurol 18 5 2003 325 330
14. R.E. Burke, and S. Fahn Double-blind evaluation of trihexyphenidyl in dystonia Adv Neurol 37 1983 189 192
15. A.H. Hoon Jr., P.O. Freese, E.M. Reinhardt, and et al. Age-dependent effects of trihexyphenidyl in extrapyramidal cerebral palsy Pediatr Neurol 25 1 2001 55 58
16. J.E. Visser, D.J. Schretlen, B.R. Bloem, and H.A. Jinnah Levodopa is not a useful treatment for Lesch-Nyhan disease Mov Disord 26 4 2011 746 749
17. V.D. Nunes, L. Sawyer, J. Neilson, G. Sarri, and J.H. Cross Diagnosis and management of the epilepsies in adults and children: summary of updated NICE guidance BMJ 344 2012 e281
18. R.E. Burke, S. Fahn, C.D. Marsden, S.B. Bressman, C. Moskowitz, and J. Friedman Validity and reliability of a rating scale for the primary torsion dystonias Neurology 35 1 1985 73 77
19. M.C. Elze, H. Gimeno, K. Tustin, L. Baker, D.E. Lumsden, J.L. Hutton, and J.-P. Lin Burke-Fahn-Marsden dystonia severity, gross motor, manual ability and communication function classification scales in childhood hyperkinetic movement disorders including cerebral palsy: a Rosetta Stone study Dev Med Child Neurol 58 2 2016 Feb 145 153